The US Department of Agriculture approved the genetically modified purple tomato to extend its shelf life and boost nutritional quality almost 15 years after its development.
According to biochemist Cathie Martin, she and her colleagues at Norfolk Plant Scientists (NPS) have been experimenting with pigment production in flowering plants for over two decades, and they've spent almost 15 months developing the purple tomato.
The NPS has been focusing on anthocyanins, the antioxidant-rich pigments that give blackberries and blueberries their signature shades.
Domesticated tomatoes already have genes to produce anthocyanins, but they are not 'turned on.' By carefully adding two genes, the tomatoes and juice become a rich source of antioxidants, because purple pigments are made in the whole tomato, not just the skins.
While there are already some purple-skinned tomatoes, their pigments mostly stop at the outer layers and don't accumulate in the fruit itself.
The NPS also emphasized that there is increasing evidence to show that antioxidants work much better when consumed within foods.
The USDA Animal and Plant Health Inspection Service (APHIS) reported that the tomato was modified to alter its color and enhance its nutritional quality, adding that the plant is unlikely to pose an increased plant pest risk compared to other cultivated tomatoes.
Nathan Pumplin, the CEO of NPS' US-based commercial business, said they are optimistic that they can begin limited distribution of purple tomatoes in the US by 2023.


Oil Prices Rebound as Trump Orders Blockade of Sanctioned Venezuelan Tankers
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Oil Prices Slip in Asia as 2026 Supply Glut Fears and Russia-Ukraine Talks Weigh on Markets
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Australian Consumer Sentiment Slumps in Early December as Inflation Fears Resurface
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Asian Currencies Trade Sideways as Dollar Weakens Ahead of Key U.S. Data
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Gold and Silver Surge as Safe Haven Demand Rises on U.S. Economic Uncertainty
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 



